Top Suppliers:I want be here

120993-53-5

120993-53-5 structure
120993-53-5 structure
  • Name: Desirudin
  • Chemical Name: Desirudin
  • CAS Number: 120993-53-5
  • Molecular Formula: C287H440N80O110S6
  • Molecular Weight:
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease Thrombin
  • Create Date: 2018-10-16 18:57:00
  • Modify Date: 2025-08-25 07:30:47
  • Desirudin (CGP 39393) is a thrombin inhibitor. Desirudin can inhibit the formation of blood clots and venous stasis thrombosis, which is used for the research of thrombocytopenia or platelet dysfunction[1][2].

Name Desirudin
Description Desirudin (CGP 39393) is a thrombin inhibitor. Desirudin can inhibit the formation of blood clots and venous stasis thrombosis, which is used for the research of thrombocytopenia or platelet dysfunction[1][2].
Related Catalog
Target

ED50: 0.01 mg/kg (i.v.) and 0.45 mg/kg (s.c.)[2].

In Vivo Desirudin (CGP 39393, 0.75-3.0 mg/kg, a bolus plus infusion administration, dogs model of cardiopulmonary bypass) is effective in Inhibiting clot formation[1]. Desirudin (0.01-1 mg/kg approximately, Intravenous injections and subcutaneous injection, rat shunt model) inhibits thrombus development with ED50 values of 0.3 mg/kg (i.v.) and 1.0 mg/kg (s.c.), and inhibits venous stasis thrombosis with ED50 values of 0.01 mg/kg (i.v.) and 0.45 mg/kg (s.c.)[2]. Animal Model: Male mongrel dogs model of cardiopulmonary bypass[1] Dosage: 1.0 mg/kg + 0.75 mg/kg/h, 1.0 mg/kg + 1.50 mg/kg/h, 1.0 mg/kg + 2.25 mg/kg/h, 1.0 mg/kg + 3.0 mg/kg/h. Administration: Administered as a bolus plus infusion Result: Inhibits clot formation with no adverse hemodynamic or hematologic effects. Animal Model: Rat shunt model of thrombus formation on a cotton-thread[2] Dosage: 0.01-1 mg/kg approximately Administration: Intravenous injections, subcutaneous injection Result: Inhibited thrombus development with ED50 values of 0.3 mg/kg (i.v.) and 1.0 mg/kg (s.c.). Inhibited venous stasis thrombosis with ED50 values of 0.01 mg/kg (i.v.) and 0.45 mg/kg (s.c.).
References

[1]. J M Walenga, et al. Evaluation of CGP 39393 as the Anticoagulant in Cardiopulmonary Bypass Operation in a Dog Model. Ann Thorac Surg. 1994 Dec;58(6):1685-9.

[2]. M D Talbot, et al. Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo. Thromb Haemost. 1989 Feb 28;61(1):77-80.

Molecular Formula C287H440N80O110S6
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.